Cost of treatment of schizophrenia in six European countries
- 30 June 2009
- journal article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 111 (1-3), 70-77
- https://doi.org/10.1016/j.schres.2009.03.027
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UKCurrent Medical Research and Opinion, 2008
- Special Section on Implications of CATIE: Lessons to Take Home From CATIEPsychiatric Services, 2008
- Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in SchizophreniaArchives of General Psychiatry, 2006
- Decision models in the evaluation of psychotropic drugsThe European Journal of Health Economics, 2006
- A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in GermanyThe European Journal of Health Economics, 2006
- Pharmacoeconomic modelling in schizophreniaThe European Journal of Health Economics, 2006
- A comparison of several regression models for analysing cost of CABG surgeryStatistics in Medicine, 2003
- The European Service Mapping Schedule (ESMS): development of an instrumentfor the description and classificationof mental health servicesActa Psychiatrica Scandinavica, 2000
- Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international researchThe British Journal of Psychiatry, 2000
- Utilisation of mental health services and costs of patients with schizophrenia in three areas of SpainThe British Journal of Psychiatry, 1998